ProCE Banner Activity

Expert Audio From Italy and France on Strategies to Reduce HCV Incidence in Key Populations

Audio

This on-demand audio features expert perspectives on HCV elimination efforts in Italy and France and highlights globally applicable lessons on treatment as prevention.

Released: August 27, 2019

Expiration: August 25, 2020

No longer available for credit.

Share

Faculty

Alessio Aghemo

Alessio Aghemo, MD, PhD

Associate Professor of Gastroenterology
Department of Biomedical Sciences
Humanitas University
Division of Internal Medicine and Hepatology
Department of Gastroenterology
Humanitas Research Hospital
Milan, Italy

Karine Lacombe

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from

Gilead

Partners

INHSU

ProCE Banner

Faculty Disclosure

Primary Author

Alessio Aghemo, MD, PhD

Associate Professor of Gastroenterology
Department of Biomedical Sciences
Humanitas University
Division of Internal Medicine and Hepatology
Department of Gastroenterology
Humanitas Research Hospital
Milan, Italy

Alessio Aghemo, MD, PhD, has disclosed that he has received consulting fees and fees for non-CME/CE services from AbbVie, Gilead Sciences, Intercept, and Merck; has received funds for research support from AbbVie; and has ownership interest in Aimmune Therapeutics.

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

Karine Lacombe, MD, PhD, has disclosed that she has received consulting fees from AbbVie, Gilead Sciences, and Janssen.